Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1992
[Dual inhibition of converting enzyme and neutral endopeptidase: a research new way in the field of hypertension]M C Fournie-Zaluski
Neurochemistry International|May 27, 2010
Design and evaluation of inhibitors of enkephalin degrading enzymesM C Fournie-Zaluski
Neuroscience|December 1, 1996
Opposite role of delta 1- and delta 2-opioid receptors activated by endogenous or exogenous opioid agonists on the endogenous cholecystokinin system: further evidence for delta-opioid receptor heterogeneityF Noble, M C Fournie-Zaluski, B P Roques
Trends in Endocrinology and Metabolism: TEM|April 11, 2001
Angiotensin III: a central regulator of vasopressin release and blood pressureA Reaux, M C Fournie-Zaluski, C Llorens-Cortes
International Journal of Peptide and Protein Research|September 1, 1987
Comparison of conformational properties of linear and cyclic delta selective opioid ligands DTLET (Tyr-D X Thr-Gly-Phe-Leu-Thr) and DPLPE (Tyr-c[D X Pen-Gly-Phe-Pen]) by 1H n.m.r. spectroscopyJ Belleney, B P Roques, M C Fournie-Zaluski
Molecular Pharmacology|March 1, 1986
Proposals for the mu-active conformation of the enkephalin analog Tyr-cyclol(-N gamma-D-A2-bu-Gly-Phe-Leu-)B Maigret, M C Fournie-Zaluski, B Roques, et al.
International Journal of Peptide and Protein Research|May 1, 1991
Computational analysis of conformational behavior of cholecystokinin fragments. I-CCK4, CCK5, CCK6 and CCK7 moleculesD Pattou, B Maigret, M C Fournie-Zaluski, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalinsO Valverde, R Maldonado, M C Fournie-Zaluski, et al.
FEBS Letters|November 25, 1998
Differences in transition state stabilization between thermolysin (EC 3.4.24.27) and neprilysin (EC 3.4.24.11)C Marie-Claire, E Ruffet, G Tiraboschi, et al.
European Journal of Biochemistry|March 1, 1984
Differences in the structural requirements for selective interaction with neutral metalloendopeptidase (enkephalinase) or angiotensin-converting enzyme. Molecular investigation by use of new thiol inhibitorsM C Fournie-Zaluski, E Lucas, G Waksman, et al.
Pageof 6